Company page

Havn Life Sciences Inc

Havn Life Sciences Inc, trading under the ticker HAVN, is a public company based in Canada with a market capitalization of approximately CAD 557,801.225. The company focuses on the development and commercialization of psychedelic compounds for therapeutic use. Havn Life aims to advance research in the field of mental health and wellness through innovative solutions.